Amgen

Amgen is committed to improving the lives of people with serious diseases by making the best use of biology and technology. The company focuses on developing innovative and effective biologics and biosimilars within various therapeutic areas, including oncology, hematology, cardiovascular disease, osteoporosis and inflammatory diseases. Since its founding in 1980, Amgen has become one of the world's leading biotechnology companies, reaching millions of patients worldwide. Amgen's Belgian subsidiary has about 150 employees engaged in a wide range of activities, from clinical development to commercial operations.